A Phase 3 interventional study of Desloratadine (Clarinex) and Cetirizine (Zyrtec) in Allergic Rhinitis, sponsored by Organon and Co. Completed. Open to participants aged 6 Years to 11 Years. Per ClinicalTrials.gov, last updated 2022-02-16.
Sponsored by Organon and Co · Phase 3, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Rhinitis, Allergic by Organon & Co. — none open to participants now, none under way, none of them phase 3. Rhinitis, Allergic · Organon & Co..
Among the 21 studies in Rhinitis, Allergic by Organon & Co., this one is the 10th largest by enrollment of the 20 interventional ones that give a count, is one of 5 that started in 2004, is one of 14 in phase 3, and was the 15th registered.
717 studies on the registry are indexed under Rhinitis, Allergic; 94 are open to participants now.
Browse Rhinitis, Allergic studies →None of the 21 studies in Rhinitis, Allergic by Organon & Co. is open now. The open studies under Rhinitis, Allergic, anywhere →
Of the 54 Rhinitis, Allergic studies recruiting now, 11 (20%) set no upper age limit and 38 (70%) stop at 75 or younger; 22 take children under 18; 13 take healthy volunteers.
This study: 6 Years to 11 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 5 started in 2004.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 202 is above the median of 68 across 552 interventional studies indexed under Rhinitis, Allergic.
Median enrollment 197 across the 20 interventional studies, 3,806 across the 1 observational. Of the 21 that completed or were terminated, 10 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under Organon and Co, one of the names counted as Organon & Co.. Under that name alone:
Organon and Co is the lead sponsor of 505 studies on the registry; none are open to participants now.
Of its 23 completed or terminated interventional studies of FDA-regulated products, 18 (78%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 21 studies in Rhinitis, Allergic by Organon & Co., from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day.
This study is a cross-over study design.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subjects must be:
Exclusion Criteria:
Subjects who:
To compare the preference in taste between desloratadine and cetirizine.
Drug: Desloratadine (Clarinex) · Drug: Cetirizine (Zyrtec)
Each subject received 5 mL of desloratadine syrup one time
Also known as: SCH 034117, Clarinex
Each subject received 5 mL of cetirizine syrup
Also known as: Zyrtec
Taste acceptability as determined from smiley-face scale of 1 (frowning child) to 5 (happy child face).
Time frame: During the only study visit
Taste flavor preference between bubble-gum, banana-grape, or grape flavors
Time frame: During the only study visit
Adverse Events
Time frame: During the only study visit
No study locations are listed for this record.
The record gives a start of Nov 2004, a primary completion of Nov 2004 and a completion of Nov 2004. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Desloratadine · Cetirizine